3. Role of Carbogen in the Treatment of Head and Neck Cancer

Vaupel P. , Kallinowski F. , Okunieff P. . Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989; 49: 6449–6465.

Thomlinson R.H. , Gray L.H. . The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955; 9: 539–549.

Bush R.S. , Jenkins R.D. , Allt W.E. . Definitive evidence of hypoxic cells influencing cure in cancer therapy. Br J Cancer. 1978; 37: 302–306.

Overgaard J. , Horsman M.R. . Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and radiosensitizers. Semin Radiat Oncol. 1996; 6: 10–21.

Nordsmark M. , Overgaard M. , Overgaard J. . Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radioher Oncol. 1996; 41: 31–39.

Kaanders J.H. , Pop L.A. , Marres H.A. . Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol. 1998; 48: 115–122.

Siemann D.W. . The tumor microenvironment: a double-edged sword. Int J Radiat Oncol Biol Phys. 1998; 42: 697–699.

Stuben G. , Stuschke M. , Knuhmann K. . The effect of combined nicotinamide and carbogen treatments in human tumour xenographs: oxygenation and tumour control studies. Radiother Oncol. 1998; 48: 143–148.

Powell M.E. , Collingridge D.R. , Saunders M.I. . Improvement in human tumour oxygenation with carbogen of varying carbon dioxide concentrations. Radiother Oncol. 1999; 50: 167–171.

Mendenhall W.M. , Parsons J.T. . Altered fractionation in radiation therapy for squamous-cell carcinoma of the head and neck. Cancer Invest. 1998; 16: 594–603.